Concepedia

Publication | Closed Access

Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.

35

Citations

35

References

2006

Year

Gerhard Glatting, Marguerite Müller, Bernd Koop, Kathrin Hohl, Claudia Friesen, Bernd Neumaier, Eleanor Berrie, Pru Bird, G Hale, Norbert M. Blumstein,
PubMed

Abstract

This study shows that the anti-CD45 monoclonal antibody YAML568 is suitable for delivering selectively radiation to hematopoietic tissues when labeled with 90Y provided that a preloading dose of about 0.5 mg/kg unlabeled antibody is given.

References

YearCitations

Page 1